Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Paratesticular rhabdomyosarcoma].

B P Mamveev, L L Gurariĭ, M I Volkova

    Urologiia (Moscow, Russia : 1999)
    |June 19, 2003
    PubMed
    Summary

    Paratesticular rhabdomyosarcoma (PR) is a common tumor in men, often spreading to retroperitoneal lymph nodes. Treatment involves surgery, lymphadenectomy, and adjuvant therapies, with prognosis depending on disease stage and age.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Abundance of Tumor-Infiltrating B Cells in Human Epithelial Malignancies.

    Acta naturae·2024
    Same author

    The Role of Methylation of a Group of microRNA Genes in the Pathogenesis of Metastatic Renal Cell Carcinoma.

    Bulletin of experimental biology and medicine·2023
    Same author

    Computer-aided Evaluation of Polyvalent Medications' Pharmacological Potential. Multiphytoadaptogen as a Case Study.

    Molecular informatics·2022
    Same author

    [Molecular Diagnostics of the Involvement of Visually Normal Mucosa in the Malignancy Process in Urothelial Bladder Cancer].

    Molekuliarnaia biologiia·2022
    Same author

    Panel of Candidate Genes to Predict the Survival of Patients with Clear Cell Renal Cancer on the Basis of Gene Expression Regulated by HIF1α/HIF2α.

    Bulletin of experimental biology and medicine·2022
    Same author

    [Possibilities of in silico estimations for the development of pharmaceutical composition phytoladaptogene cytotoxic for bladder cancer cells].

    Biomeditsinskaia khimiia·2021

    Area of Science:

    • Oncology
    • Urology

    Context:

    • Paratesticular rhabdomyosarcoma (PR) is the most common paratesticular tumor.
    • It primarily affects young and middle-aged men.
    • Early metastasis to retroperitoneal lymph nodes is characteristic.

    Purpose:

    • To outline the diagnostic and treatment strategies for paratesticular rhabdomyosarcoma.
    • To discuss the role of surgery, lymphadenectomy, and adjuvant therapies.
    • To highlight factors influencing the prognosis of PR.

    Summary:

    • Orchofuniculectomy is the primary treatment for PR.
    • Metastases-free patients receive preventive retroperitoneal lymphadenectomy and adjuvant chemoradiotherapy.
    • Disseminated PR requires combined treatment, including surgical removal of foci and adjuvant chemo- or chemoradiotherapy. Chemotherapy is used if complete surgical removal is not possible.
    • Radiation therapy for metastatic retroperitoneal lymph nodes is ineffective.

    Impact:

    • Provides a comprehensive overview of PR management.
    • Emphasizes the importance of multimodal treatment approaches.
    • Informs prognosis based on age, stage, and treatment effectiveness.

    Related Experiment Videos